天能重工(300569.SZ)公告称，公司于2025年5月6日收到持股5%以上股东郑旭的《关于协议转让终止事 项的告知函》，因市场环境等原因，本次股转协议解除，交易终止。郑旭原计划向长安信托转让其持有 的公司无限售流通股股份61,180,000股（占总股本比例5.98%），但截至公告披露之日，该股份尚未办 理过户手续，未发生实质转让。本次协议转让终止不会导致公司控制权变化，不会对公司治理结构及日 常生产经营造成影响。 ...

Group 1: Investment Trends of Super Investors - Super investors in A-shares have shown a significant divergence in investment directions, with a focus on computing power and humanoid robots by individual investors, while billion-dollar private equity firms have concentrated on materials and resources sectors [1] - Notable individual investor Zhang Jianping has heavily increased his stake in computing power concepts, becoming a top shareholder in companies like Hangang Steel and Aofei Data, while also increasing his holdings in Cambrian [1] - Investor Ge Weidong has entered the top ten shareholders of Su Da Weige, holding 1.62 million shares valued at approximately 30 million yuan, indicating a strategic focus on micro-nano optical materials and communication industries [1] Group 2: Private Equity Movements - Over 20 billion-dollar private equity firms have appeared in the first quarter reports of listed companies, with firms like Gao Yi Asset and Xuan Yuan Private Equity being particularly active [3] - Gao Yi Asset has newly entered the top ten shareholders of companies such as Guoci Materials and China Aluminum, while increasing stakes in Longbai Group and Zijin Mining, and reducing holdings in Hikvision and Yangnong Chemical [3] - Xuan Yuan Private Equity has also made significant moves, entering the top ten shareholders of Huabao Co. and Stanley, while reducing positions in companies like Jidong Equipment [4] Group 3: Sector Focus and Company Highlights - The computing power and humanoid robot sectors are gaining traction among individual investors, with companies like Zhongjian Technology being highlighted as key players in the humanoid robot concept [1][2] - The materials and resources sectors are favored by private equity firms, with companies like Wolong Nuclear Materials receiving attention from multiple billion-dollar private equity products [4] - The first quarter has seen a notable increase in collaboration agreements between companies like Zhongding Co. and various robot enterprises, positioning Zhongding as a leader in the humanoid robot sector [2]

关于召开 2024 年年度股东大会的通知 | 证券代码：300569 | 证券简称：天能重工 | 公告编号：2025-047 | | --- | --- | --- | | 转债代码：123071 | 转债简称：天能转债 | | 青岛天能重工股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 青岛天能重工股份有限公司（以下简称"公司"）2025 年 4 月 29 日召开公 司第五届董事会第七次会议，审议通过了《关于召开 2024 年年度股东大会的议 案》，定于 2025 年 5 月 21 日召开公司 2024 年年度股东大会（以下简称"股东 大会"）。现将召开股东大会的相关事项通知如下： 一、召开会议的基本情况 1、股东大会届次：2024 年年度股东大会。 2、股东大会的召集人：公司董事会。 3、会议召开的合法、合规性：本次股东大会的召集程序符合有关法律、法 规、部门规章、规范性文件和《公司章程》的有关规定。 4、会议召开的日期、时间： （1）现场召开日期和时间：2025 年 5 月 21 日（星期三）下午 14:30。 （2）网络投票日期和时间：2 ...

| 证券代码：300569 | 证券简称：天能重工 | 公告编号：2025-049 | | --- | --- | --- | | 转债代码：129071 | 转债简称：天能转债 | | 青岛天能重工股份有限公司 （一）审议《关于补选李春梅女士为公司董事的议案》 董事会同意补选李春梅女士为公司第五届董事会非独立董事，任期自公司股 东大会选举通过之日起至第五届董事会届满。 具体内容详见公司同日于巨潮资讯网（www.cninfo.com.cn）上披露的《关 于董事辞职暨补选董事的公告》。 表决结果：同意 8 票；反对 0 票；弃权 0 票。 第五届董事会第七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 青岛天能重工股份有限公司（以下简称"公司"）第五届董事会第七次会议 于 2025 年 4 月 29 日在公司会议室以通讯方式召开，会议通知于 2025 年 4 月 29 日以电话、口头方式向各位董事发出。本次会议为紧急临时会议，董事长在本次 会议上就紧急召开本次会议的情况进行了说明，公司全体董事均同意豁免本董事 会会议的通知 ...

| 证券代码：300569 | 证券简称：天能重工 | 公告编号：2025-048 | | --- | --- | --- | | 转债代码：123071 | 转债简称：天能转债 | | 青岛天能重工股份有限公司 青岛天能重工股份有限公司 关于董事辞职暨补选董事的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、关于董事辞职的情况 青岛天能重工股份有限公司（以下简称"公司"）董事会近日收到刘博韬先 生的辞职报告。刘博韬先生因工作安排原因辞去所担任的公司第五届董事会董事、 战略发展与 ESG 委员会委员职务，辞职后不再担任公司及子公司任何职务。刘博 韬先生原定董事任期为：2024 年 12 月 24 日至 2027 年 12 月 23 日。 刘博韬先生的辞职不会导致公司董事会成员低于法定最低人数，根据《公司 法》及《公司章程》的有关规定，刘博韬先生的辞职申请自送达董事会之日起生 效。截至本公告日，刘博韬先生未直接或间接持有公司股份，不存在应当履行而 未履行的承诺事项，其在原定任期内和任期届满后六个月内将继续遵守《深圳证 券交易所上市公司股东及董事、监事、 ...

Group 1 - Shenjian Co., Ltd. reported a net profit of 33.65 million yuan for 2024, a year-on-year increase of 32.29%, with a proposed cash dividend of 0.5 yuan per 10 shares [1] - Jingce Electronics experienced a net loss of 97.60 million yuan in 2024, transitioning from profit to loss, despite a revenue increase of 5.59% to 2.565 billion yuan [1] - Jingwei Co., Ltd. reported a net profit of 35.54 million yuan for 2024, a decrease of 36.76%, with a proposed cash dividend of 1.00 yuan per 10 shares [1][2] Group 2 - Minsheng Health achieved a net profit of 91.83 million yuan in 2024, a year-on-year increase of 7.24%, with a proposed cash dividend of 1.00 yuan per 10 shares [2] - Zhongshe Co., Ltd. reported a net profit of 10.16 million yuan for 2024, a decline of 76.24%, with a proposed cash dividend of 0.2 yuan per 10 shares [3] - Keyuan Smart reported a net profit of 252 million yuan for 2024, a year-on-year increase of 56.64%, with a proposed cash dividend of 0.4 yuan per 10 shares [4] Group 3 - Beilu Pharmaceutical reported a net profit of 14.54 million yuan for Q1 2025, a year-on-year increase of 26.13%, with revenue of 283 million yuan [5] - Wangsu Technology achieved a net profit of 192 million yuan for Q1 2025, a year-on-year increase of 38.54%, with revenue of 1.235 billion yuan [6] - Keyuan Pharmaceutical reported a net profit of 23.08 million yuan for Q1 2025, a year-on-year increase of 7.25%, despite a revenue decline of 23.98% [7] Group 4 - Guangting Information reported a net profit of 24.03 million yuan for Q1 2025, turning from loss to profit, with revenue of 134 million yuan [9] - Zhaori Technology reported a net loss of 1.23 million yuan for Q1 2025, with revenue of 35.23 million yuan [11] - Huakai Yibai reported a net loss of 15.09 million yuan for Q1 2025, despite revenue growth of 35.08% to 2.292 billion yuan [13] Group 5 - Xinhongye reported a net profit of 34.43 million yuan for Q1 2025, a year-on-year increase of 20.43%, with revenue of 755 million yuan [15] - Huning Co., Ltd. reported a net profit of 3.61 million yuan for Q1 2025, a year-on-year decrease of 45.68%, with revenue of 64.51 million yuan [16] - Camel Co., Ltd. reported a net profit of 237 million yuan for Q1 2025, a year-on-year increase of 51.89%, with revenue of 4.136 billion yuan [17] Group 6 - Hengtong Co., Ltd. reported a net profit of 42.55 million yuan for Q1 2025, a year-on-year increase of 51.62%, with revenue of 313 million yuan [19] - Changqing Technology reported a net profit of 35.38 million yuan for Q1 2025, a year-on-year decrease of 23.80%, with revenue of 246 million yuan [21] - Libaba Co., Ltd. reported a net profit of 34.72 million yuan for Q1 2025, a year-on-year increase of 9.91%, with revenue of 419 million yuan [22] Group 7 - Shouxiangu reported a net profit of 58.37 million yuan for Q1 2025, a year-on-year decrease of 24.32%, with revenue of 171 million yuan [24] - Bojun Technology announced a stock issuance application accepted by the Shenzhen Stock Exchange [24] - Dayou Energy announced the full resumption of production at its Gengcun coal mine, with an annual production capacity of 3.6 million tons [25] Group 8 - Deyang Co., Ltd. successfully acquired land use rights for industrial land in Ningbo for 45.80 million yuan [27] - Tianyu Pharmaceutical's subsidiary received a drug registration certificate for an injectable product [29] - Xingwang Yuda signed a strategic cooperation agreement with the Jilin Province Bionic Robot Innovation Center [30] Group 9 - Lifang Pharmaceutical received approval for clinical trials of a new drug [32] - Zai Sheng Technology reported a net profit of 33.56 million yuan for Q1 2025, a year-on-year increase of 3.69%, with revenue of 324 million yuan [34] - Jinxin Technology reported a net profit of 319,920 yuan for Q1 2025, turning from loss to profit, with revenue of 563 million yuan [36] Group 10 - Huayin Electric reported a net profit of 75.67 million yuan for Q1 2025, a year-on-year increase of 894.61%, with revenue of 2.307 billion yuan [37] - Xinghua Co., Ltd. reported a net loss of 95.51 million yuan for Q1 2025, with revenue of 840 million yuan [38] - Heren Technology reported a net loss of 384,410 yuan for Q1 2025, with revenue of 78.40 million yuan [40] Group 11 - Fenda Technology reported a net profit of 40.45 million yuan for Q1 2025, a year-on-year increase of 84.07%, with revenue of 760 million yuan [41] - Tongda Co., Ltd. reported a net profit of 25.49 million yuan for 2024, a year-on-year decrease of 69.15%, with revenue of 6.201 billion yuan [43] - Zhonghe Holdings reported a net profit of 283 million yuan for 2024, a year-on-year decrease of 54.69%, with a proposed cash dividend of 0.3 yuan per 10 shares [44] Group 12 - Jiantou Energy reported a net profit of 531 million yuan for 2024, a year-on-year increase of 181.59%, with a proposed cash dividend of 1.3 yuan per 10 shares [44] - Guanghua Technology reported a net loss of 205 million yuan for 2024, with revenue of 2.589 billion yuan [45] - Huajin Technology reported a net profit of 29.26 billion yuan for 2024, a year-on-year increase of 8.1%, with a proposed cash dividend of 9 yuan per 10 shares [46] Group 13 - Yingke Medical reported a net profit of 1.465 billion yuan for 2024, a year-on-year increase of 282.63%, with a proposed cash dividend of 1.00 yuan per 10 shares [46] - Solar Energy reported a net profit of 1.225 billion yuan for 2024, a year-on-year decrease of 22.38%, with a proposed cash dividend of 0.56 yuan per 10 shares [46] - Dongfang Electric reported a net profit of 318 million yuan for 2024, a year-on-year decrease of 50.62%, with a proposed cash dividend of 0.32 yuan per 10 shares [47] Group 14 - Tianneng Heavy Industry reported a net loss of 262 million yuan for 2024, with revenue of 3.273 billion yuan [48] - Gangyan High-tech reported a net profit of 249 million yuan for 2024, a year-on-year decrease of 22.08%, with a proposed cash dividend of 1.00 yuan per 10 shares [48] - Shihua Machinery reported a net profit of 96.88 million yuan for 2024, a year-on-year increase of 5.35%, with revenue of 8.037 billion yuan [49] Group 15 - Gongtong Pharmaceutical reported a net loss of 27.59 million yuan for 2024, with revenue of 537 million yuan [51] - Zhongjing Electronics reported a net loss of 87.43 million yuan for 2024, with revenue of 2.932 billion yuan [53] - Yudai Development reported a net loss of 114 million yuan for 2024, with revenue of 388 million yuan [55] Group 16 - Zhenhua Technology reported a net profit of 970 million yuan for 2024, a year-on-year decrease of 63.83%, with a proposed cash dividend of 1.8 yuan per 10 shares [56] - Jierong Technology reported a net loss of 298 million yuan for 2024, with revenue of 1.357 billion yuan [58] - Changgao Electric New reported a net profit of 252 million yuan for 2024, a year-on-year increase of 45.66%, with a proposed cash dividend of 0.8 yuan per 10 shares [60] Group 17 - Shibao Detection announced a plan to acquire 81% of Zhonghuan Lianshu for 52.65 million yuan [61] - Jiangsu Boyun announced a plan to reduce its shareholding by up to 3% [62] - Jingfeng Mingyuan announced a plan to acquire 100% of Yichong Technology for 3.283 billion yuan [63]

Market Overview - The Shanghai Composite Index closed at 3297.29 points, slightly above the annual line, with a change of 0.03% [1] - The total trading volume of A-shares reached 1,138.919 billion yuan [1] Stocks Breaking Annual Line - A total of 54 A-shares have surpassed the annual line today, with notable stocks showing significant deviation rates [1] - The stocks with the highest deviation rates include: - Erkang Pharmaceutical (19.70%) - Ketaobiotechnology (9.60%) - Tianneng Group (7.76%) [1] - Other stocks with smaller deviation rates that just crossed the annual line include: - Gongyuan Co., Ltd. - Dongfang Shenghong - Jiumuwang [1] Top Performing Stocks - The top stocks with the highest daily increase and their respective metrics are: - Erkang Pharmaceutical: +20.00% with a turnover rate of 9.08% [1] - Ketaobiotechnology: +11.58% with a turnover rate of 13.57% [1] - Tianneng Group: +13.84% with a turnover rate of 12.01% [1] - Other notable performers include: - Bangjie Co., Ltd.: +9.89% - CGN Technology: +10.08% [1] Summary of Deviation Rates - The deviation rates of stocks that have recently crossed the annual line are as follows: - Bangjie Co., Ltd.: 7.20% - CGN Technology: 6.05% - Jinkai Biotechnology: 4.48% [1] - Additional stocks with lower deviation rates include: - YN Holdings: 3.25% - Huadian Energy: 2.93% [1]

青岛天能重工股份有限公司 关于 2024 年度内部控制的自我评价报告 青岛天能重工股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求 （以下简称"企业内部控制规范体系"），结合青岛天能重工股份有限公司（以下 简称"公司"）内部控制制度和评价办法，在内部控制日常监督和专项监督的基础 上，我们对公司 2024 年 12 月 31 日（内部控制评价报告基准日）的内部控制有效性 进行了评价。 一、重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有 效性，并如实披露内部控制评价报告是公司董事会的责任。监事会对董事会建立和 实施内部控制进行监督。经理层负责组织领导企业内部控制的日常运行。公司董事 会、监事会及董事、监事、高级管理人员保证本报告内容不存在任何虚假记载、误 导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个别及连带法 律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相 关信息真实完整，提高经营效率和效果，促进实现发展战略。由于内部控制存在固 有局限性，故仅能对实现上述目标提供合理保证。此外，由于情况的 ...

| 证券代码：300569 | 证券简称：天能重工 | 公告编号：2025-039 | | --- | --- | --- | | 转债代码：123071 | 转债简称：天能转债 | | 青岛天能重工股份有限公司 关于公司及合并报表范围子公司向银行申请综合授信额度 （敞口）及为子公司的融资提供担保并进行授权的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别风险提示： 公司拟申请担保总额度预计为不超过人民币 5 亿元。本次被担保对象均为公 司合并报表范围内的全资子公司，存在对资产负债率超过 70%的全资子公司提供 担保的情形。本议案尚需提交公司股东大会审议，敬请投资者关注投资风险。 一、为公司及合并报表范围内子公司申请综合授信及授权情况 青岛天能重工股份有限公司（以下简称"公司"）于 2025 年 4 月 22 日审议 通过了《关于公司及合并报表范围子公司向银行申请综合授信额度（敞口）及为 子公司的融资提供担保并进行授权的议案》。为了满足公司及合并报表范围子公 司在生产经营过程中可能产生的金融业务需求，缓解潜在资金压力，公司及合并 报表范围子公司拟向银 ...

青岛天能重工股份有限公司 董事会审计委员会对会计师事务所 2024 年度履职情况评估及履行监督职责情况的报告 青岛天能重工股份有限公司（以下简称"公司"）董事会审计委员会根据《中 华人民共和国公司法》《中华人民共和国证券法》《上市公司治理准则》《国有 企业、上市公司选聘会计师事务所管理办法》《深圳证券交易所上市公司自律监 管指引第 2 号——创业板上市公司规范运作》和公司《公司章程》《审计委员会 工作细则》等规定和要求，现对立信会计师事务所（特殊普通合伙）（以下简称 "立信"）2024 年度履职评估情况及公司董事会审计委员会履行监督职责情况 汇报如下： 一、会计师事务所基本情况 会计师事务所名称：立信会计师事务所（特殊普通合伙） 成立日期：2011 年 01 月 24 日 2024 年度同行业上市公司审计客户家数：44 家 二、聘任会计师事务所履行的程序 注册地址：上海市黄浦区南京东路 61 号四楼 首席合伙人：朱建弟 2024 年度末合伙人数量：296 人 2024 年度末注册会计师人数：2,498 人 2024 年度末签署过证券服务业务审计报告的注册会计师人数：743 人 2024 年度收入总额（未经审计 ...